IRMD
IRadimedAAI scenario view
RankAlpha Sentiment AIThe current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
Consensus targets cluster near $98–$100, signaling mixed-to-neutral expectations with the median below the anchor [#SERP-4]. Short-term sentiment will hinge on earnings and contract news; concentrated ownership and target revisions can amplify moves [#SERP-1].
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
Upcoming FY2025/Q4 results and any guidance revision could move price; no firm release date disclosed so conservatively set to 90 days out [#SERP-6].
New purchasing wins or broadened OR/MRI-suite adoption would materially lift revenue run-rate; timing tied to multi-quarter procurement cycles so use one-year horizon [#SERP-4].
Clinical study results or regulatory clarity that expands addressable market could trigger larger re-rating; assumed one-year horizon absent public timetable [#SERP-8].
Recommendation
No formal recommendation provided.

